laitimes

Shanxi medical consumables procurement "three medical linkage" more than 20,000 selected products average price reduction of nearly 90%.

Shanxi medical consumables procurement "three medical linkage" more than 20,000 selected products average price reduction of nearly 90%.

Shanxi Province's medical consumables centralized procurement of "three medical linkage", the implementation of medical insurance fund prepayment and other supporting measures. (Data map) Photo by Wu Qiong

Taiyuan, China, December 16 (Wu Qiong) Orthopedic trauma consumables 71 enterprises selected 20,751 products, the average price drop of 88.65%. Among them, the price of the locking (universal) pressurized bone plate system dropped from an average of 9360 yuan to 987 yuan; the price of the intramedullary nail system dropped from an average of 11687 yuan to 1271 yuan.

On the 16th, the reporter learned the above news from the Shanxi Provincial Medical Insurance Bureau. From January 1, 2022, all public medical institutions in the province will fully implement the results of the "Eight Provinces and Two Districts" coronary guidance silk and the "Twelve Provinces Alliance" orthopedic trauma medical consumables centralized procurement results.

Shanxi Province's medical consumables centralized procurement "three medical linkage", the implementation of medical insurance fund prepayment, medical insurance payment standards and purchase price coordination, medical insurance fund balance retention incentive assessment and other supporting measures, to encourage hospitals to give priority to the procurement and use of reliable quality, reasonable price of the selected products.

In terms of coronary artery guide silk consumables, a total of 13 enterprises (including 7 imported enterprises and 6 domestic enterprises) were selected from 985 specifications under 44 registration certificates, and the selected products fell from the average price of 1547.15 yuan to 594.5 yuan, an average decrease of 61.57%.

The Shanxi Provincial Medical Insurance Bureau said that it will continue to deepen the reform of the centralized procurement system for drugs and medical consumables, expand the scope of medical consumables with quantity procurement varieties, and reduce the burden of medication on the public. (End)

Read on